Sufentanil citrate and Ceftriaxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sufentanil citrate (sufentanil citrate) and Ceftriaxone (ceftriaxone sodium). Common drug interactions include toxic epidermal necrolysis among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Sufentanil citrate and Ceftriaxone. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Sufentanil citrate?

Sufentanil citrate has active ingredients of sufentanil citrate. eHealthMe is studying from 1,794 Sufentanil citrate users. Check the latest studies of Sufentanil citrate.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.



On Jul, 13, 2026

23 people who take Sufentanil citrate and Ceftriaxone together, and have interactions are studied.

Sufentanil citrate and Ceftriaxone drug interactions.

What are the common drug interactions of Sufentanil Citrate and Ceftriaxone, by gender? *:

female:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Cerebral venous thrombosis (clot in brains venous blood system)
  3. Abdominal sepsis (abdominal infection)
  4. Abnormal faeces (abnormal stool)
  5. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  6. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  7. Hypokalaemia (low potassium)
  8. Multi-organ failure (multisystem organ failure)
  9. Neutrophilia
  10. Post procedural complication

male:

  1. Blood creatinine increased
  2. Renal failure (kidney dysfunction)
  3. Renal impairment (severely reduced kidney function)
  4. Renal injury (kidney injury)
  5. Stress
  6. Transaminases increased
  7. Alanine aminotransferase increased
  8. Arrhythmia (irregular heartbeat)
  9. Aspartate aminotransferase increased
  10. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)

What are the common drug interactions of Sufentanil Citrate and Ceftriaxone, by age (0-1 to 60+)? *:

0-1:

  1. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  2. Hypokalaemia (low potassium)

2-9:

n/a

10-19:

  1. Blood creatinine increased
  2. Transaminases increased
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  6. Gamma-glutamyltransferase increased
  7. Hepatocellular injury (liver injury)
  8. Renal failure (kidney dysfunction)

20-29:

  1. Creatinine renal clearance increased
  2. Drug effect decreased
  3. Heart rate increased
  4. Polyuria (production of too much dilute urine)
  5. Weight decreased

30-39:

n/a

40-49:

  1. Cerebral venous thrombosis (clot in brains venous blood system)
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  3. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  4. Ventricular fibrillation (abnormally irregular heart rhythm)
  5. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)

50-59:

n/a

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Renal impairment (severely reduced kidney function)
  4. Renal injury (kidney injury)
  5. Stress
  6. Arrhythmia (irregular heartbeat)
  7. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  8. Neutrophilia
  9. Psychiatric symptom
  10. Psychological trauma

What are the existing conditions these people have? *

  1. Infection: 9 people, 39.13%
  2. Pain: 8 people, 34.78%
  3. Sedation: 4 people, 17.39%
  4. Anaesthesia: 4 people, 17.39%
  5. Stress And Anxiety: 2 people, 8.70%
  6. Pneumonia: 2 people, 8.70%
  7. High Blood Pressure: 2 people, 8.70%
  8. Haemodynamic Instability (disturbances in the blood movement in our body): 2 people, 8.70%
  9. Cardiac Failure Congestive: 2 people, 8.70%
  10. Breast Cancer: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Sufentanil citrate and Ceftriaxone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sufentanil citrate and Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sufentanil citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sufentanil citrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftriaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sufentanil citrate and ceftriaxone sodium (the active ingredients of Sufentanil citrate and Ceftriaxone, respectively), and Sufentanil citrate and Ceftriaxone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: